Summary
Serum nifedipine concentrations and hemodynamic changes were evaluated in ten healthy volunteers after a single 40-mg oral dose of nifedipine. Peak serum concentrations averaged 45 µg/l, attained 2.7 h after dosage. The mean elimination half-life was 5.9 h (range: 3–12 h). Blood pressure, ventricular rate, and echocardiographically-determined rate of circumferential fiber shortening did not differ between placebo and nifedipine trials. Five additional subjects ingested nifedipine once in the control state and on a second occasion with a standard breakfast. Coingestion of food delayed the peak serum nifedipine concentration but did not alter the area under the serum concentration curve. Thus the pharmacokinetic profile of nifedipine indicates that a three- or four-times-daily dose is, in general, appropriate in clinical practice. Completeness of absorption is not altered by coadministration with food. Adverse hemodynamic effects of single oral doses in healthy persons are not evident.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Braunwald E (1982) Calcium-channel blockers: Pharmacologic considerations. Am Heart J 104:665–672
Rämsch K-D (1981) Zur Pharmakokinetik von Nifedipin. Schwerpunkt Medizin 4:55–61
Corvol P, Marre M, Banzet O, Colin JN, Thibonnier M, Singlas E, Alexandre JM (1982) Acute antihypertensive effects and pharmacokinetic parameters of a new galenic form of nifedipine. In: Kaltenbach M, Neufeld HN (eds) New Therapy of Ischemic Heart Disease and Hypertension (5th International Adalat Symposium). Excerpta Medica, Amsterdam Oxford Princeton, pp 158–162
Foster TS, Hamann SR, Richards VR, Bryant PJ, Graves DA, McAllister RG (1983) Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects. J Clin Pharmacol 23:161–170
Ochs HR, Grube E, Greenblatt DJ, Woo E, Bodem G (1980) Intravenous quinidine: Pharmacokinetic properties and effects on left ventricular performance in humans. Am Heart J 99:468–475
Jacobsen P, Petersen OL, Mickelsen E (1979) Gas chromatographic determination of nifedipine and one of its metabolites using electron capture detection. J Chromatogr 162:81–87
MacGregor GA, Markandu ND, Rotellar C, Smith SJ, Sagnella GA (1982) Contrasting effects of nifedipine in normotensive and hypertensive subjects: a functional abnormality of smooth muscle in essential hypertensives. In: Kaltenbach M, Neufeld HN (eds) New Therapy of Ischemic Heart Disease and Hypertension (5th International Adalat Symposium). Excerpta Medica, Amsterdam Oxford Princeton, pp 111–118
Lorell BH, Paulus WJ, Grossman W, Wynne J (1982) Improved left ventricular diastolic properties in hypertrophic cardiomyopathy treated with nifedipine. In: Kaltenbach M, Neufeld HN (eds) New Therapy of Ischemic Heart Disease and Hypertension (5th International Adalat Symposium). Excerpta Medica, Amsterdam Oxford Princeton, pp 91–97
Jansen W, Tauchert M, Hombach V, Niehues B, Behrenbeck DW, Hilger HH (1983) Hämodynamische und koronare Wirkung verschiedener Kalziumantagonisten unter Ruhebedingungen. Med Welt 34:275–281
Author information
Authors and Affiliations
Additional information
Supported in part by Grant Oc 10/6-4 from Deutsche Forschungsgemeinschaft
Rights and permissions
About this article
Cite this article
Ochs, H.R., Rämsch, K.D., Verburg-Ochs, B. et al. Nifedipine: Kinetics and dynamics after single oral doses. Klin Wochenschr 62, 427–429 (1984). https://doi.org/10.1007/BF01742301
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01742301